Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASND Ascendis Pharma A/S

盘前交易 07-29 04:32:11 EDT

164.16

-3.31

-1.98%

最高171.89	最低164.04	成交量43.54万
今开170.50	昨收167.47	日振幅4.69%
总市值99.41亿	流通市值98.63亿	总股本6,055万
成交额7,235万	换手率0.72%	流通股本6,008万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":164.16,"timestamp":1753732800000,"preClose":167.47,"halted":0,"volume":435392,"delay":0,"floatShares":60083367,"shares":60554408,"eps":-6.293925,"marketStatus":"盘前交易","change":-3.31,"latestTime":"07-29 04:32:11 EDT","open":170.5,"high":171.888,"low":164.04,"amount":72354853.23008001,"amplitude":0.046862,"askPrice":175,"askSize":10,"bidPrice":154.2,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-6.293925,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753795800000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1422421200000,"exchange":"NASDAQ","adjPreClose":164.16,"postHourTrading":{"tag":"盘后","latestPrice":164.16,"preClose":164.16,"latestTime":"19:59 EDT","volume":4317,"amount":708674.76,"timestamp":1753747173645},"volumeRatio":1.045805387753276,"impliedVol":0.6101,"impliedVolPercentile":0.9317},"requestUrl":"/m/hq/s/ASND","defaultTab":"news","newsList":[{"id":"2550392655","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550392655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550392655?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:56","pubTimestamp":1752069364,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时56分，Ascendis Pharma A/S股票出现波动，股价快速上涨5.12%。截至发稿，该股报176.78美元/股，成交量12.3713万股，换手率0.20%，振幅4.80%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.01%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215604953c3a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709215604953c3a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0889565916.HKD","ASND","BK4585","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2546249409","title":"Ascendis Pharma A/S盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546249409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546249409?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:42","pubTimestamp":1750862550,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时42分，Ascendis Pharma A/S股票出现波动，股价快速下挫5.39%。截至发稿，该股报169.44美元/股，成交量17.2388万股，换手率0.28%，振幅4.94%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.78%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625224230a71d3f33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625224230a71d3f33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","ASND","LU0889565916.HKD","BK4585","BK4139","LU0109394709.USD"],"gpt_icon":0},{"id":"2542334522","title":"B of A Securities：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由201.00美元调整至216.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542334522","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542334522?lang=zh_cn&edition=full","pubTime":"2025-06-10 02:12","pubTimestamp":1749492770,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由201.00美元调整至216.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/10021250958231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"2540772471","title":"B of A Securities：维持Ascendis Pharma评级，由买入调整至买入评级, 目标价由196.00美元调整至201.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540772471","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540772471?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:30","pubTimestamp":1748957443,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由196.00美元调整至201.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213457950d024e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213457950d024e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2540799521","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540799521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540799521?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:11","pubTimestamp":1748873503,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时11分，Ascendis Pharma A/S股票出现异动，股价快速上涨5.25%。截至发稿，该股报171.40美元/股，成交量9.8226万股，换手率0.16%，振幅3.91%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.73%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602221144950b9c4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602221144950b9c4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0889565916.HKD","BK4585","LU0109394709.USD","LU0320765992.SGD","ASND"],"gpt_icon":0},{"id":"2534501284","title":"Ascendis Pharma A/S盘中异动 临近收盘急速下挫5.11%报151.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534501284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534501284?lang=zh_cn&edition=full","pubTime":"2025-05-10 03:55","pubTimestamp":1746820537,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日03时55分，Ascendis Pharma A/S股票出现异动，股价急速跳水5.11%。截至发稿，该股报151.24美元/股，成交量43.2641万股，换手率0.72%，振幅6.19%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为3.89%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510035537a478893a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510035537a478893a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","ASND","BK4585","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2534669437","title":"Ascendis Pharma A/S2025财年第一财季实现净利润-99.59百万美元，同比增加29.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534669437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534669437?lang=zh_cn&edition=full","pubTime":"2025-05-10 00:00","pubTimestamp":1746806446,"startTime":"0","endTime":"0","summary":"5月10日，Ascendis Pharma A/S公布财报，公告显示公司2025财年第一财季净利润为-99.59百万美元，同比增加29.87%；其中营业收入为1.06亿美元，同比增加1.92%，每股基本收益为-1.66美元。从资产负债表来看，Ascendis Pharma A/S总负债13.52亿美元，其中短期债务5.29亿美元，资产负债比为0.85，流动比率为1.04。机构评级：截至2025年5月10日，当前有17家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为221.73美元，其中最低目标价为192.77美元，最高目标价为287.17美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510000401a4785ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250510000401a4785ecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2533650539","title":"Ascendis Pharma A/S盘中异动 急速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650539?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:07","pubTimestamp":1746551251,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时07分，Ascendis Pharma A/S股票出现波动，股价急速下跌5.13%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为5.71%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。该信息摘要如下：大摩：上调Ascendis Pharma评级，由持股观望调整至增持评级, 目标价由180.00美元调整至250.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050701073194ee355b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050701073194ee355b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","ASND","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2533301248","title":"大摩：上调Ascendis Pharma评级，由持股观望调整至增持评级, 目标价由180.00美元调整至250.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533301248","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533301248?lang=zh_cn&edition=full","pubTime":"2025-05-05 17:32","pubTimestamp":1746437537,"startTime":"0","endTime":"0","summary":"大摩：上调Ascendis Pharma(ASND.US)评级，由持股观望调整至增持评级, 目标价由180.00美元调整至250.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050517370494eccf7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050517370494eccf7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2532878871","title":"小摩：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由200.00美元调整至245.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532878871","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532878871?lang=zh_cn&edition=full","pubTime":"2025-05-03 01:41","pubTimestamp":1746207707,"startTime":"0","endTime":"0","summary":"小摩：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由200.00美元调整至245.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/03014150110472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"2532829529","title":"Wedbush：维持Ascendis Pharma(ASND.US)评级，由优于大市调整至优于大市评级, 目标价由181.00美元调整至212.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532829529","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532829529?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:55","pubTimestamp":1746201313,"startTime":"0","endTime":"0","summary":"Wedbush：维持Ascendis Pharma(ASND.US)评级，由优于大市调整至优于大市评级, 目标价由181.00美元调整至212.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02235550109620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"1126170845","title":"异动解读 | 分析师上调目标价，Ascendis Pharma盘中大涨7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126170845","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126170845?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:53","pubTimestamp":1746194035,"startTime":"0","endTime":"0","summary":"周五盘中，生物制药公司Ascendis Pharma A/S股价大幅上涨7.44%，引发市场关注。这一显著涨幅似乎与华尔街知名投行的最新研究报告密切相关。根据最新消息，Evercore ISI Group分析师重申了对Ascendis Pharma的\"优于大市\"评级，同时将目标价从260美元上调至280美元。Evercore ISI Group的积极评估无疑提振了投资者信心。尽管具体细节尚未披露，但这一评级调整显然激发了市场对Ascendis Pharma的热情，推动其股价在当日交易中大幅上扬。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 分析师上调目标价，Ascendis Pharma盘中大涨7.44%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"gpt_icon":0},{"id":"2532445198","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨8.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532445198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532445198?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:32","pubTimestamp":1746192759,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时32分，Ascendis Pharma A/S股票出现异动，股价急速上涨8.68%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.33%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。该信息摘要如下：Ascendis Pharma：2025年Q1财报实现营收1.062亿美元，前值为1.041亿美元，预期值为9488万美元；每股收益为-1.66美元，前值为-2.50美元，预期值为-1.51美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213239974d650e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213239974d650e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0109394709.USD","ASND"],"gpt_icon":0},{"id":"2532884963","title":"Evercore ISI Group：维持Ascendis Pharma(ASND.US)评级，由优于大市调整至优于大市评级, 目标价由260.00美元调整至280.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532884963","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532884963?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:11","pubTimestamp":1746191499,"startTime":"0","endTime":"0","summary":"Evercore ISI Group：维持Ascendis Pharma(ASND.US)评级，由优于大市调整至优于大市评级, 目标价由260.00美元调整至280.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/02211150108306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EVR","ASND"],"gpt_icon":0},{"id":"2526619742","title":"Ascendis Pharma A/S盘中异动 下午盘急速上涨5.37%报151.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526619742?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:40","pubTimestamp":1744393225,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时40分，Ascendis Pharma A/S股票出现异动，股价快速上涨5.37%。截至发稿，该股报151.03美元/股，成交量16.1693万股，换手率0.27%，振幅5.73%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.46%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014025aa2c6d1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014025aa2c6d1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4139","LU0320765992.SGD","ASND","BK4585"],"gpt_icon":0},{"id":"2518208844","title":"Ascendis Pharma A/S盘中异动 急速下跌5.16%报138.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208844?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:43","pubTimestamp":1741624985,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时43分，Ascendis Pharma A/S股票出现异动，股价快速下挫5.16%。截至发稿，该股报138.22美元/股，成交量11.4887万股，换手率0.19%，振幅3.85%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.67%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004306abf34219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004306abf34219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD","ASND","BK4585"],"gpt_icon":0},{"id":"2514097967","title":"坎托菲茨杰拉德公司：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由170.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097967","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514097967?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由170.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0},{"id":"2512611921","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512611921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512611921?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:31","pubTimestamp":1739892667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时31分，Ascendis Pharma A/S股票出现异动，股价急速拉升5.50%。截至发稿，该股报152.00美元/股，成交量16.6641万股，换手率0.28%，振幅4.35%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.59%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233107abd3bcfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233107abd3bcfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0889565916.HKD","LU0109394709.USD","BK4139","ASND","LU0320765992.SGD"],"gpt_icon":0},{"id":"2511704046","title":"Ascendis Pharma A/S2024财年实现净利润-4.09亿美元，同比增加21.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511704046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511704046?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:01","pubTimestamp":1739635295,"startTime":"0","endTime":"0","summary":"2月16日，Ascendis Pharma A/S公布财报，公告显示公司2024财年净利润为-4.09亿美元，同比增加21.35%；其中营业收入为3.93亿美元，同比增加36.46%，每股基本收益为-7.06美元。从资产负债表来看，Ascendis Pharma A/S总负债13.31亿美元，其中短期债务5.09亿美元，资产负债比为0.92，流动比率为1.17。机构评级：截至2025年2月16日，当前有16家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为201.57美元，其中最低目标价为162.69美元，最高目标价为290.23美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000204abd030f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000204abd030f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2511957350","title":"高盛：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由200.00美元调整至225.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511957350","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511957350?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:38","pubTimestamp":1739468289,"startTime":"0","endTime":"0","summary":"高盛：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由200.00美元调整至225.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14013848150593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":-0.023},{"period":"1month","weight":-0.0468},{"period":"3month","weight":-0.0145},{"period":"6month","weight":0.287},{"period":"1year","weight":0.2274},{"period":"ytd","weight":0.1924}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司，该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品，TransCon人生长激素或生长激素TransCon，每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.028378},{"month":2,"riseRate":0.545455,"avgChangeRate":0.052339},{"month":3,"riseRate":0.454545,"avgChangeRate":0.035071},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.034117},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.003499},{"month":6,"riseRate":0.636364,"avgChangeRate":0.020914},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.004584},{"month":8,"riseRate":0.7,"avgChangeRate":0.081464},{"month":9,"riseRate":0.6,"avgChangeRate":0.041437},{"month":10,"riseRate":0.4,"avgChangeRate":-0.012194},{"month":11,"riseRate":0.8,"avgChangeRate":0.046776},{"month":12,"riseRate":0.5,"avgChangeRate":0.04575}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}